Description

Retatrutide (GLP-3) is an advanced investigational peptide designed to target three key metabolic hormone receptors — GLP-1, GIP, and glucagon receptors — to support weight management and metabolic health research. This next-generation multi-agonist compound is being studied for its potential effects on appetite regulation, energy expenditure, glucose metabolism, and fat reduction.

Researchers are exploring Retatrutide for its promising role in obesity, type 2 diabetes, and metabolic disorder studies due to its unique triple-action mechanism. Early clinical findings have demonstrated significant interest in its ability to promote substantial body weight reduction and improve metabolic markers.

Our RETATRUTIDE (GLP-3) products are manufactured under strict quality standards and intended strictly for laboratory and research purposes only. Not for human consumption or clinical use.